FDA Inspection 1316716 — Reproductive Partners Medical Group - La Jolla Inc.
The FDA completed an inspection of Reproductive Partners Medical Group - La Jolla Inc. on Apr 27, 2026 in La Jolla, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 27, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- La Jolla, CA (United States)